Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 02 - 23 tags : Therapeutics save search
Intellia Therapeutics Enters Lease Agreement to Build Manufacturing Facility for its CRISPR-based Therapies
Published: 2022-02-23 (Crawled : 19:00) - biospace.com/
NTLA | $21.17 -1.67% 590K
|
Health Technology
|
| O: 1.57%
H: 1.39%
C: -6.39%
therapeutics crispr intel therapy
Poseida Therapeutics Hosts Second Annual Virtual R&D Day Highlighting Novel Pipeline Assets and Latest Technology Innovations
Published: 2022-02-23 (Crawled : 19:00) - biospace.com/
PSTX | $2.07 -4.17% 240K
|
Health Technology
|
| O: 1.38%
H: 0.0%
C: -3.95%
day technology therapeutics test set
Rani Therapeutics Unveils High-Capacity RaniPill™ Device For Oral Delivery of Biologics; Reports Preliminary 2021 Consolidated Financial Results
Published: 2022-02-23 (Crawled : 19:00) - biospace.com/
RANI | $6.49 -2.99% 82K
|
|
| O: 3.45%
H: 8.59%
C: -11.52%
financial results device liver therapeutics report results
Horizon Therapeutics plc Initiates Phase 3 Clinical Trial (OPTIC-J) in Japan Evaluating Teprotumumab for the Treatment of Active Thyroid Eye Disease (TED)
Published: 2022-02-23 (Crawled : 19:00) - biospace.com/
HZNP | $116.3 0.03% 29M
|
Health Technology
|
| O: 0.97%
H: 0.38%
C: -2.35%
treatment eye eye disease trial therapeutics disease active phase 3
Cyclerion Therapeutics and Ariana Pharma Announce an Artificial Intelligence-driven Precision Medicine Collaboration
Published: 2022-02-23 (Crawled : 13:00) - globenewswire.com
CYCN | $3.05 670
|
Health Technology
|
| O: 1.96%
H: 1.91%
C: -4.63%
artificial intelligence therapeutics intel collaboration pharma
Jounce Therapeutics to Announce Fourth Quarter and Full Year 2021 Financial Results and Host Conference Call on Wednesday, March 2, 2022
Published: 2022-02-23 (Crawled : 13:00) - globenewswire.com
JNCE | $1.88 -2.59% -1.85% 0
|
Health Technology
|
| O: 1.25%
H: 0.96%
C: -2.61%
GILD | $66.81 -0.33% 4.4M
|
Health Technology
|
| O: -0.02%
H: 1.08%
C: 0.62%
day financial results conference therapeutics results
Entrada Therapeutics to Participate in Cowen 42nd Annual Health Care Conference
Published: 2022-02-23 (Crawled : 13:00) - globenewswire.com
TRDA | $12.6 -2.25% 16K
|
Professional, Scientific, and T...
|
| O: 0.67%
H: 1.46%
C: -17.76%
health conference therapeutics
Finch Therapeutics to Participate in the Chardan Metagenomics and Microbiome Medicines Summit
Published: 2022-02-23 (Crawled : 12:00) - globenewswire.com
FNCH | $2.31 -17.17% 100K
|
Professional, Scientific, and T...
|
| O: -1.84%
H: 0.0%
C: -2.7%
genomics genomic therapeutics
Relmada Therapeutics Announces Top-Line Results of Study Evaluating REL-1017 vs Ketamine for Abuse Potential
Published: 2022-02-23 (Crawled : 12:00) - prnewswire.com
RLMD | $3.87 -1.02% 83K
|
Health Technology
|
| O: 12.21%
H: 0.24%
C: -4.88%
rel-1017 ketamine therapeutics potential topline
G1 Therapeutics Provides Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights
Published: 2022-02-23 (Crawled : 12:00) - globenewswire.com
GTHX | $3.985 -4.89% 260K
|
Health Technology
|
| O: 7.37%
H: 2.15%
C: -5.7%
financial results therapeutics results
Verve Therapeutics to Present at the Cowen 42nd Annual Healthcare Conference
Published: 2022-02-23 (Crawled : 12:00) - globenewswire.com
VERV | $6.62 -3.78% 490K
|
Professional, Scientific, and T...
|
| O: 1.17%
H: 1.63%
C: -2.39%
health thc conference therapeutics
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
CSSE 4 | $0.3831 151.54% 190M
|
Consumer Services
CZOO | $11.04 121.24% 11M
|
LICN | $0.9107 62.63% 14M
|
BOF | $1.87 59.83% 100M
|
AMST | $3.18 59.0% 67M
|
Technology Services
MTC | $3.31 47.77% 7.7M
|
Technology Services
MULN | News | $3.915 43.41% 12M
|
Information
WIMI | $1.04 43.37% 17M
|
Technology Services
SKIL 4 | $8.045 40.89% 230K
|
Information
RILY | $30.01 38.17% 11M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.